BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11980629)

  • 1. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
    Reimer MK; Holst JJ; Ahrén B
    Eur J Endocrinol; 2002 May; 146(5):717-27. PubMed ID: 11980629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity.
    Mitani H; Takimoto M; Hughes TE; Kimura M
    Jpn J Pharmacol; 2002 Apr; 88(4):442-50. PubMed ID: 12046988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.
    Deacon CF; Wamberg S; Bie P; Hughes TE; Holst JJ
    J Endocrinol; 2002 Feb; 172(2):355-62. PubMed ID: 11834453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
    Ahrén B; Holst JJ; Mårtensson H; Balkan B
    Eur J Pharmacol; 2000 Sep; 404(1-2):239-45. PubMed ID: 10980284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
    Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
    Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
    Ahrén B; Simonsson E; Larsson H; Landin-Olsson M; Torgeirsson H; Jansson PA; Sandqvist M; Båvenholm P; Efendic S; Eriksson JW; Dickinson S; Holmes D
    Diabetes Care; 2002 May; 25(5):869-75. PubMed ID: 11978683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV inhibitor NVP-DPP728 ameliorates early insulin response and glucose tolerance in aged rats but not in aged Fischer 344 rats lacking its enzyme activity.
    Mitani H; Takimoto M; Kimura M
    Jpn J Pharmacol; 2002 Apr; 88(4):451-8. PubMed ID: 12046989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
    Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
    Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I
    Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats.
    Furrer D; Kaufmann K; Tschuor F; Reusch CE; Lutz TA
    Vet J; 2010 Mar; 183(3):355-7. PubMed ID: 19128990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Yoshikawa S; Asano O; Tanaka I
    Biochem Biophys Res Commun; 2001 Jun; 284(2):501-6. PubMed ID: 11394909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
    Sudre B; Broqua P; White RB; Ashworth D; Evans DM; Haigh R; Junien JL; Aubert ML
    Diabetes; 2002 May; 51(5):1461-9. PubMed ID: 11978643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats.
    Yasuda N; Nagakura T; Yamazaki K; Inoue T; Tanaka I
    Life Sci; 2002 May; 71(2):227-38. PubMed ID: 12031691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
    Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
    Ahrén B; Sörhede Winzell M; Burkey B; Hughes TE
    Eur J Pharmacol; 2005 Oct; 521(1-3):164-8. PubMed ID: 16171801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)- pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV.
    Hughes TE; Mone MD; Russell ME; Weldon SC; Villhauer EB
    Biochemistry; 1999 Sep; 38(36):11597-603. PubMed ID: 10512614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.